ClinicalTrials.Veeva

Menu

Accuracy of Amniotic Fluid Lamellar Body Counting for Evaluating of Fetal Lung Maturity

I

Isfahan University of Medical Sciences

Status and phase

Completed
Phase 2

Conditions

Retained Fetal Lung Fluid

Treatments

Other: Amniotic fluid Lamellar Body Counting

Study type

Interventional

Funder types

Other

Identifiers

NCT01463722
ASD-1213-20

Details and patient eligibility

About

The purpose of this study is to determine the accuracy of Amniotic fluid Lamellar Body Counting for Evaluating of Fetal Lung Maturity.

Full description

Respiratory distress syndrome (RDS) is one of important cause of mortality in neonates. This study was designed to evaluate the amniotic fluid lamellar body counting for predicting fetal lung maturity.

Enrollment

128 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women, with 28-37 weeks of gestational age, who had been decided to terminate their pregnancy, were enrolled in the study

Exclusion criteria

  • Chorioamnionitis
  • Intra Uterine Fetal Death (IUFD)
  • Blood in amniotic fluid
  • Rupture of placenta and patient dissatisfaction were the exclusion criteria.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Single Blind

128 participants in 1 patient group

Amniotic fluid Lamellar Body Counting
Other group
Treatment:
Other: Amniotic fluid Lamellar Body Counting

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems